Deferoxamine01 (Deferoxamine01)
Deferoxamine Mesylate
Product Images NDC 52609-4504
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferoxamine Mesylate (NDC 52609-4504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apopharma Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Deferoxamine500mg (Deferoxamine02)
Deferoxamine Mesylate Injection, USP is available in 500 mg vials for subcutaneous, intramuscular, or intravenous administration. It contains 500 mg of Dferoxamine mesylate USP in lyophilized form. ApoPharma produces and distributes the product, which should be reconstituted with sterile water for injection before use. The recommended dosage is a single 500 mg vial. The product should be stored at controlled room temperature and kept out of the reach of children. Validated aseptic conditions should be maintained during reconstitution, and reconstituted solutions should not be refrigerated but used within 24 hours. Detailed instructions are provided in the package insert.*
Deferoxamine2g (Deferoxamine03)
This is a product description for Deferoxamine Mesylate for Injection produced by ApoPharma. The injection is designed for subcutaneous, intramuscular, or intravenous administration. Each vial contains 2g of lyophilized Deferoxamine Mesylate USP. The recommended dosage is 2g for each day of use. The injection must be stored between 20-25 degrees Celsius and in a controlled room environment. The product can be identified through its NDC number of 5200845043 for use with a prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
